samarium has been researched along with Hormone-Dependent Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bushnell, D; Higano, CS; Quick, DP; Sartor, O | 1 |
1 other study(ies) available for samarium and Hormone-Dependent Neoplasms
Article | Year |
---|---|
Safety analysis of repeated high doses of samarium-153 lexidronam in men with hormone-naive prostate cancer metastatic to bone.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Neoplasms; Dose-Response Relationship, Drug; Feasibility Studies; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Samarium; Survival Rate | 2008 |